The European Society
of Human Genetics

Scientific Programme

EMPAG Scientific Programme

as per April 23, 2010

Saturday, June 12, 2010

14:30 - 15:30

ES3. EMPAG/ESHG Educational Session: Communication in Clinical Genetics

Communication between patients/families and genetic professionals
Clara Gaff, Victoria, Australia

How genetics affect family dynamics
John Rolland, Chicago, IL, United States

15:45 - 16:15

Opening : common with ESHG Welcome addresses

16:15 - 18:00

EPL1 - EMPAG Plenary Session: Individual and social perception of genetic results

Room G4

EPL1.1.Adapting to the new genetic status after predictive testing for Huntington's disease - the experiences of non-carriers
E. Winnberg
1, U. Almqvist1, A. Hagberg2, T. Bui3;
1
Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden, 2Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden, 3Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.

EPL1.2. Early experiences with a genetic disorder: consequences in later life
L. B. Van der Meer1, A. Tibben1,2;
1Leiden University Medical Center, Leiden, Netherlands, 2Erasmus Medical Center, Rotterdam, Netherlands.

EPL1.3. Living with Huntington's disease from the partner's perspective
A. J. A. G. Van Tongerloo, A. M. J. J. De Paepe;
University Hospital Gent, 9000 Gent, Belgium.

EPL1.4 The Challenge of Adolescent Clients: Using Predictive Testing for FAP as a Case Study for Exploring Developmentally Appropriate Care
R. E. Duncan1,2, M. B. Delatycki3, L. Gillam4,5, S. M. Sawyer6,5;
1Murdoch Childrens Research Institute, Parkville, Victoria, Australia, 2Centre for Adolescent Health, Bruce Lefroy Centre for Genetic Health Research & Children's Bioethics Centre, Royal Children's Hospital, Melbourne, Australia, 3Bruce Lefroy Centre for Genetic Health Research, Melbourne, Australia, 4Children's Bioethics Centre, Royal Children's Hospital, Parkville, Victoria, Australia, 5Murdoch Children's Research Institute, Melbourne, Australia, 6Centre for Adolescent Health, Royal Children's Hospital & Department of Paediatrics, University of Melbourne, Melbourne, Australia.

EPL1.5 Empowerment: Development and validation of a new outcome measure for evaluating genetic counselling interventions
M. McAllister1, A. M. Wood1, G. Dunn1, S. Shiloh2, C. Todd1;
1The University of Manchester, Manchester, United Kingdom, 2The University of Tel Aviv, Tel Aviv, Israel.

EPL1.6 'All is done by Allah'? Understandings of Down syndrome in Pakistan
L. Bryant
1, S. Ahmed1, M. Ahmed2, H. Jafri3, Y. Rashid4;
1Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom, 2Department of Clinical Genetics, Leeds Hospitals Teaching NHS Trust, Leeds, United Kingdom, 3Gentec Laboratory, Lahore, Pakistan, 4Department of Obstetrics and Gynaecology, Rawalpindi Medical College, Rawalpindi, Pakistan.

18:00 - 18:30Coffee break
18.30 - 20:00

EPL2 - EMPAG Plenary Session: Psychosocial issues in cardiac genetics

Room G4

EPL2.1 The impact of predictive gene testing for hypertrophic cardiomyopathy and long QT syndrome
I. Macciocca1,2, O. Ukoumunne3,2, A. Davis4,5, R. Weintraub4, V. Connell4, L. Yeates6,7, J. Ingles8,7, M. Delatycki9,5, S. Wake1,2, C. Semsarian10,7, W. J. McKenna11,12, T. Marteau13, V. Collins5;
1Genetic Health Services Victoria, Murdoch Childrens Research Institute, Parkville, Melbourne, Australia, 2University of Melbourne, Melbourne, Australia, 3Murdoch Childrens Research Institute, Parkville, Melbourne, Australia, 4Royal Children's Hospital, Melbourne, Australia, 5Murdoch Childrens Research Institute, Melbourne, Australia, 6Royal Prince Alfred Hospital, Sydney, Australia, 7Centenary Institute, Sydney, Australia, 8Royal Brisbane and Women's Hospital, Brisbane, Australia, 9Austin Health, Melbourne, Australia, 10University of Sydney, Sydney, Australia, 11University College London, London, United Kingdom, 12University College London Hospitals, London, United Kingdom, 13Kings College London, London, United Kingdom.

EPL2.2 Risk factors for sudden cardiac death and follow-up in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers
I. Christiaans1, I. M. van Langen1, E. Birnie2, G. J. Bonsel2, A. A. M. Wilde3;
1Academic Medical Centre, Department of Clinical Genetics, Amsterdam, Netherlands, 2Erasmus Medical Centre, Institute of Health Policy and Management, Rotterdam, Netherlands, 3Academic Medical Centre, Department of Cardiology, Amsterdam, Netherlands.

EPL2.3 Adolescents with implantable cardioverter defibrillators: a patient and parent perspective
B. Rahman1, I. Macciocca2, M. Sahhar2, S. Kamberi3, V. Connell3, R. Duncan4;
1University of Melbourne, Melbourne, Australia, 2Genetic Health Services Victoria, Murdoch Childrens Research Institute, Melbourne, Australia, 3Royal Children's Hospital, Melbourne, Australia, 4Centre for Adolescent Health, Murdoch Childrens Research Institute, Melbourne, Australia.

EPL2.4 Congenital heart defects and heredity: what do adult patients know and want to know?
K. van Engelen1, M. J. H. Baars1, L. T. van Rongen1, E. T. van der Velde2, E. M. A. Smets1, B. J. M. Mulder1;
1Academic Medical Center, Amsterdam, Netherlands, 2Leiden University Medical Center, Leiden, Netherlands.

EPL2.5 Family letters are an effective way to inform relatives about inherited cardiac disease
W. P. van der Roest1, J. M. Pennings2, M. Bakker1, M. P. van den Berg3, J. P. van Tintelen1;
1University Medical Center Groningen, University of Groningen, department of Genetics, Groningen, Netherlands, 2University Medical Center Groningen, University of Groningen, department of health science/metamedica, Groningen, Netherlands, 3University Medical Center Groningen, University of Groningen, department of Cardiology, Groningen, Netherlands.

EPL2.6 Prenatal and preimplantation diagnoses in Marfan syndrome: the point of view of French patients and geneticists
F. Coron
1, G. Jondeau2, V. Cusin2, S. Odent3, O. Dulac4, H. Plauchu5, P. Collignon6, M. Delrue7, B. Leheup8, C. Cassini1, C. Thauvin-Robinet1, C. Boileau9, L. Faivre1;
1Centre de génétique, Hopital d'Enfants, Dijon, France, 2Centre de référence Maladie de Marfan, Hôpital Bichat, Paris, France, 3Service de génétique, Rennes, France, 4Service de génétique, Toulouse, France, 5Service de génétique, Lyon, France, 6Service de génétique, Marseille, France, 7Service de génétique, Bordeaux, France, 8Service de génétique, Nancy, France, 9Laboratoire de biologie moléculaire, Hôpital Ambroise Paré, Boulogne, France.

20:00 - 21:30

Welcome Reception at the Göteborg Convention Centre
 

Sunday, June 13, 2010

08:45 - 10:15

ESHG/EMPAG Symposium: S02. Ethics Related to New Genetic Technologies (Joint Session with ESHG)

Ethical issues in large scale genomics research
Timothy Caulfield, Edmonton, Canada

Ethical issues in expanded newborn screening
Ellen Wright Clayton, Nashville, TN, United States

Ethical issues in PND/PGD
Guido Pennings, Gent, Belgium

10:15 - 11:30Coffee Break, Free Poster Viewing, Exhibition
11:30 - 12:15

Poster Viewing with Authors (even/odd poster numbers)

12:15 - 13:15

Lunch, Free Poster Viewing, Exhibition

13:15 - 14:45

EPL3 - EMPAG Plenary Session: Reproductive issues and newborn screening

Room G4

EPL3.1 Desirability of early identification of Duchenne Muscular Dystrophy (DMD): parents' experiences of the period prior to diagnosis
R. Eilers1, J. H. Kleinveld2, E. Vroom3, M. J. Westerman1, M. C. Cornel2,4, A. C. Plass2,5;
1VU University, Amsterdam, Netherlands, 2VU University Medical Center, Amsterdam, Netherlands, 3Duchenne Parent Project, Amsterdam, Netherlands, 4The EMGO Institute for Health and care research, Amsterdam, Netherlands, 5The EMGO Institute for Health and Care Research, Amsterdam, Netherlands.

EPL3.2 New non-invasive prenatal genetic technologies: Public understandings and concerns
H. R. Farrimond, S. E. Kelly;
University of Exeter, Exeter, United Kingdom.

EPL3.3 Attitudes and intentions to undergo invasive prenatal testing: The moderating role of ambivalence
B. B. Biesecker1, M. Hankins2, M. Schwartz3, T. Marteau2;
1National Human Genome Research Institute, Bethesda, MD, United States, 2Kings College, London, United Kingdom, 3Georgetown University, Washington DC, DC, United States.

EPL3.4 Reproductive decisions of couples with an increased risk of having a child with retinoblastoma, a cross-sectional survey
C. J. Dommering1, M. M. Garvelink1, A. C. Moll2, H. J. Meijers-Heijboer1, L. Henneman1,3;
1Department of Clinical Genetics, VU University Medical Center, Amsterdam, Netherlands, 2Department of Ophthalmology, VU University Medical Center, Amsterdam, Netherlands, 3Department of Public and Occupational Health, EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, Netherlands.

EPL3.5 Longitudinal evaluation 7 years after termination of pregnancy (TOP) on the context of prenatal diagnosis
F. Afonso1, J. Rocha1,2, P. Rendeiro2, A. Leonardo3, M. Correia4, P. Tavares2;
1UnIPSa-CICS, ISCS-N, Porto, Portugal, 2Centro Genetica Clinica, Porto, Portugal, 3H. Sta. Maria, Lisbon, Portugal, 4Mat. Alfredo Costa, Lisbon, Portugal.

EPL3.6 Exploring health professionals' views on Perinatal Hospice care: a qualitative study.
A. Horwood1, S. Buscombe2, J. Hodgson1,3;
1The University of Melbourne, Parkville, Australia, 2Peter MacCallum Cancer Centre, East Melbourne, Australia, 3Murdoch Childrens Research Institute, Parkville, Australia.

15:00 - 16:30

EMPAG Workshops

Room G4:
EWS1.1 Teaching counselling skills for genetic counselling practice
R. M. MacLeod1, D. Scotcher1, J. Hodgson2, M. Sahhar2;
1The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom, 2Department of Paediatrics, University of Melbourne, Melbourne, Australia

Room R22+R23:
EWS2.1
Embedding genetic counsellors into clinical genetics in Europe
H. Skirton1, M. Voelckel2;
1Faculty of Health, Taunton, United Kingdom, 2Hôpital d'Enfants de la Timone, Marseille, France, Marseille, France.

 

Monday, June 14, 2010

08:45 - 10:15

EPL4- EMPAG Plenary Session: Cancer Genetics: information, counselling and treatment

Room G4

EPL4.1 What information do cancer genetic counselees prioritize?
C. Ingvoldstad1, A. Roshanai1, K. Nordin1, C. Lampic1, R. Rosenquist2;
1Department of Public Health and Caring Sciences, Uppsala University, Sweden, Uppsala, Sweden, 2Department of Genetics and Pathology, Uppsala, Sweden.

EPL4.2 Managing anxiety in individuals undergoing cancer genetic risk assessment: a self-help coping intervention can reduce psychological distress and avoidance of genetic risk information.
C. Phelps1, P. Bennett2, K. Hood2, K. Brain2, A. Murray3;
1Swansea Metropolitan University, Swansea, United Kingdom, 2Cardiff University, Cardiff, United Kingdom, 3Cancer Genetics Service for Wales, Cardiff, United Kingdom.

EPL4.3 Quality of life after breast cancer: information provision regarding DIEP flap and implant breast reconstruction
J. P. Gopie1, R. Timman2, M. A. M. Mureau2, M. T. Hilhorst2, A. Tibben1,2;
1Leiden University Medical Center, Leiden, Netherlands, 2Erasmus University Medical Center, Rotterdam, Netherlands.

EPL4.4 Acceptance, experiences and information preferences of young women newly diagnosed with breast cancer regarding treatment-focused genetic testing
B. Meiser1,2, M. Gleeson1, K. J. Watts1,2, C. Saunders3, G. Mitchell4, E. Lobb5,6, K. Barlow-Stewart7, J. Kirk8, K. Tucker1;
1Department of Medical Oncology, Prince of Wales Hospital, Sydney, NSW, Australia, 2Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia, 3School of Surgery, University of Western Australia, Perth, WA, Australia, 4Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia, 5Calvary Health Care Sydney, Kogarah, NSW, Australia, 6WA Centre for Cancer & Palliative Care, Curtin University of Technology and Edith Cowan University, Perth, WA, Australia, 7Centre for Genetics Education, Royal North Shore Hospital, Sydney, NSW, Australia, 8Familial Cancer Research Group, Westmead Millenium Institute for Medical Research, University of Sydney, Sydney, NSW, Australia.

EPL4.5 Genetic counseling between breast cancer diagnosis and treatment: Psychosocial burden and clinical consequences
D. E. E. Hahn1, M. R. Wevers1,2, S. Verhoef1, M. D. K. Bolhaar1, N. K. Aaronson1, M. G. E. M. Ausems2, E. M. A. Bleiker1;
1Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands, 2University Medical Centre Utrecht, Utrecht, Netherlands.

EPL4.6 Psychological impact of MSI testing shortly after CRC diagnosis
K. M. Landsbergen, J. B. Prins, H. G. Brunner, P. van Duijvendijk, F. M. Nagengast, M. J. L. Ligtenberg, N. Hoogerbrugge;
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

10:15 - 10:45Coffee break
11:15 - 12:15

Poster Viewing with Authors (even/odd poster numbers)

12:15 - 13:15 Lunch, Free Poster Viewing, Exhibition
13:15 - 14:45 

EC5A/C11 EMPAG Concurrent Session: Genetic Research, Biobanking and Public Policy (joint session with ESHG)

Room F6

C11.1 Policy Recommendations of the PPPC on direct-to-consumer genetic testing for health purposes
P. Borry1, C. Patch2, M. Cornel; on behalf of the PPPC3;
1Centre for Biomedical Ethics and Law, 3000, Belgium, 2Guy's Hospital, London, United Kingdom, 3VU Amsterdam, Amsterdam, Netherlands.

C11.2 Reporting genetic research results: A quasi-experimental approach to understanding researchers' judgments
R. Z. Hayeems, F. A. Miller, L. Li, J. P. Bytautas;
University of Toronto, Toronto, ON, Canada.

C11.3 Direct-to-consumer genetic testing companies: what are their policies regarding testing in minors?
H. C. Howard, P. Borry;
KULeuven, Leuven, Belgium.

C11.4 Genetic Counsellors' Views Regarding Their Role in Delivering a Pharmacogenetic Service
A. V. E. Callard, W. Newman, K. Payne;
University of Manchester, Manchester, United Kingdom.

C11.5 Informed consent for large-scale biobank research: experience and attitudes of cancer patients
J. Mancini1,2, C. Chabannon3,4, I. Pellegrini1, F. Viret3,4, N. Vey3,4, C. Julian-Reynier1;
1Inserm UMR912 SE4S, Marseille, France, 2Aix-Marseillle Université, Marseille, France, 3Inserm UMR891 CRCM, Marseille, France, 4Institut Paoli-Calmettes, Marseille, France.

C11.6 Biobanking cancer tissue. Patients consider excised (tumour) tissue to be "connective tissue".
E. Vermeulen;
VUmc, Amsterdam, Netherlands.

 
13:15 - 14:45  

EC5B - EMPAG Concurrent Session: Psycho-social issues about screening

Room F6

EC5.1 Genetic testing of newborns for type 1 diabetes susceptibility: A prospective cohort study on effects on maternal mental health
K. K. Aas1, K. Tambs1, M. S. Kise2, P. Magnus1, K. S. Rönningen1;
1Norwegian Institute of Public Health, Oslo, Norway, 2Norwegian Directorate of Health, Oslo, Norway.

EC5.2 Short-term psychological outcomes of ovarian cancer screening in women at high genetic risk
K. Brain1, K. J. Lifford1, J. Austoker2, L. Bayne3, A. Clements2, L. Fraser4, R. Iredale1, I. Jacobs4, D. Lancastle5, U. Menon4, C. Phelps6, M. T. Rogers1, A. Rosenthal4,7, E. Watson8;
1School of Medicine, Institute of Medical Genetics, Cardiff University, Cardiff, United Kingdom, 2Primary Care Research Education Group, University of Oxford, Oxford, United Kingdom, 3Ovacome, London, United Kingdom, 4Gynaecological Oncology, University College London Institute for Women's Health, London, United Kingdom, 5Department of Humanities and Social Sciences, University of Glamorgan, Pontypridd, United Kingdom, 6School of Psychology, Swansea Metropolitan University, Swansea, United Kingdom, 7Institute of Cancer, Barts and the London School of Medicine and Dentistry, Queen Mary University London, London, United Kingdom, 8School of Health and Social Care, Oxford Brookes University, Oxford, United Kingdom.

EC5.3 Psychological distress in high-risk individuals undergoing pancreatic cancer screening
T. Nagtegaal1, F. Harinck2, I. Kluijt1, C. M. Aalfs3, E. Smets3, J. Poley2, A. Wagner2, J. van Hooft3, P. Fockens3, M. J. Bruno2, E. M. A. Bleiker1;
1The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands, 2Erasmus Medical Center, Rotterdam, Netherlands, 3Academic Medical Center, Amsterdam, Netherlands.

EC5.4 Applying measures of informed decision making to population carrier screening for fragile X syndrome
S. A. Metcalfe1, A. Ames1, A. Archibald1, J. Cohen2, J. Emery3, M. Hill4,5, M. Martyn4, O. Ukoumunne1;
1Murdoch Childrens Research Institute and Dept Paediatrics, University of Melbourne, Parkville, Vic, Australia, 2Fragile X Alliance Inc and Monash University, Melbourne, Australia, 3University of Western Australia, Perth, WA, Australia, 4Murdoch Childrens Research Institute, Parkville, Vic, Australia, 5Clinical and Molecular Genetics, Institute of Child Health and Great Ormond Street Hospital, London, United Kingdom.

EC5.5 Parental feelings towards the unsought identification of newborns as carrier of sickle cell anaemia through newborn screening
A. C. Plass1,2, M. Westerman3,2, M. C. Cornel1,2;
1VU University medical center, Amsterdam, Netherlands, 2EMGO-institute for Health and Care research, Amsterdam, Netherlands, 3VU University, Amsterdam, Netherlands.

EC5.6 Knowledge and perceived risks in couples undergoing genetic testing after recurrent miscarriage or in men with poor semen quality.
F. Vansenne1, M. Goddijn1, B. Redeker1, S. Snijder1, K. Gerssen-Schoorl2, H. H. Lemmink2, N. J. Leschot1, F. van der Veen1, P. M. M. Bossuyt1, C. A. J. M. de Borgie1;
1Academic Medical Centre, Amsterdam, Netherlands, 2University Medical Center Groningen, Groningen, Netherlands.

15:00 - 16:30

EMPAG Workshops

Room G4

EWS3.1 Predictive testing for cardiogenetic conditions in children: practical considerations from a multidisciplinary team
A. M. Schiphorst
, I. Christiaans, C. M. Aalfs;
Academic Medical Center, Department of Clinical Genetics, Amsterdam, Netherlands.

EWS3.2 Cardiac chaos: A hypothetical about cardiac genetic services, issues and challenges
I. Macciocca1, I. M. van Langen2, R. Duncan3, M. Nicol4,5, S. Jenkins6,7, P. James1;
1Genetic Health Services Victoria, Melbourne, Australia, 2Department of Clinical Genetics, University Medical Centre, Groningen, Netherlands, 3Centre for Adolescent Health, Bruce Lefroy Centre for Genetic Health Research, Children's Bioethics Centre, Murdoch Childrens Research Institute., Melbourne, Australia, 4All Wales Medical Genetics Service, Cardiff and Vale University Health Board, University Hospital of Wales Cardiff, Cardiff, United Kingdom, 5Association of Inherited Cardiovascular Conditions (AICC) UK, Cardiff, United Kingdom, 6The Heart Hospital, University College London Hospitals NHS Trust, London, United Kingdom, 7University College London, London, United Kingdom.

16:30 - 17:15Coffee Break
17:15 - 18:45

S10.  ESHG/EMPAG Symposium: Patient's Associations and Patients' Involvement in Genetic Research (Joint Session with ESHG )

Patients' Organizations' Engagement in War on Rare Genetic Diseases: Scientific Activism and New Forms of Sociality
Vololona Rabeharisoa, Paris France

Transitions between research and clinical practice: families' experiences in a gene-hunting study
Helen Statham, Cambridge, United Kingdom

Genetics and mental illness: perceptions of affected individuals and their family members
Jehanine Austin Vancouver Canada

20:00Congress party
 

Tuesday, June 15, 2010

08:45 - 10:15

EPL6 - EMPAG Plenary Session: Communication on genetic issues within families

Room G4

EPL6.1 Communicating BRCA1/2 genetic test results within families: implications for genetic counselling
C. Jacobs1, C. Dancyger2, S. Michie2, J. Smith3;
1Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom, 2University College London, London, United Kingdom, 3Birkbeck College, London, United Kingdom.

EPL6.2 Psychological distress in women at risk for hereditary breast cancer: the role of family communication and perceived social support
M. den Heijer;
Erasmus MC, Rotterdam, Netherlands.

EPL6.3 Is telegenetics as effective as face-to-face consultations for hereditary breast/ovarian cancer genetic counseling?
E. M. Zilliacus1, B. Meiser2, E. A. Lobb3, K. Barlow-Stewart4, P. Kelly5, J. Kirk6, A. Spigelman7, L. Warwick8, K. Tucker9;
1University of New South Wales, Randwick, Australia, 2Department of Medical Oncology, Prince of Wales Hospital, Randwick, Australia, 3Calvary Health Care, Sydney, Australia, 4Centre for Genetics Education, North Shore Hospital, St Leonards, Australia, 5Sydney School of Public Health, Sydney, Australia, 6Familial Cancer Service, Westmead Hospital, Westmead, Australia, 7UNSW St Vincent's Clinical School, Sydney, Australia, 8ACT Genetics Service, Canberra Hospital, Woden, Australia, 9Dept Medical Oncology, Prince of Wales Hospital, Randwick, Australia.

EPL6.4 A whisper-game perspective on the family communication of DNA-test results: A retrospective study on the communication process of BRCA1/2-test results between genetic-counsellor, proband and relatives
J. Vos
1, A. M. Jansen1, F. Menko2, C. J. Van Asperen1, A. M. Stiggelbout3, A. Tibben1;
1Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands, 2Department of Clinical Genetics, VU University Medical Center, Amsterdam, Netherlands, 3Department of Medical Decision-Making, Leiden University Medical Center, Leiden, Netherlands.

EPL6.5 Taking on passing on: A grounded theory on containing cancer in BRCA carriers
L. A. Jeffers
1,2, d. Fitzsimons2,1, E. McCaughan3, P. Morrison1;
1Belfast Health and Social Care Trust, Belfast, United Kingdom, 2University of Ulster, Jordanstown, United Kingdom, 3University of Ulster, Coleraine, United Kingdom.

EPL6.6 Genetic testing for BrCa and Hungtington's disease in twins: experience of 10 cases
M. M. Bottomley, T. Clancy, G. Evans, G. Hall, W. Beckett, L. Kerzin-Storrar;
Department of Genetic Medicine, St Mary's Hospital, Manchester, United Kingdom.

10:15 - 10:45Coffee Break, Free Poster Viewing, Exhibition
10:45 - 12:15

EPL7 - EMPAG Plenary Session: Living with Risks and multifactorial diseases: implications for genetic services

Room G4

EPL7.1 Descriptive and numeric estimation of risk for psychotic disorders among affected individuals and relatives: implications for clinical practice
J. C. Austin, W. G. Honer;
University of British Columbia, Vancouver, BC, Canada.

EPL7.2 A population based study of the psychosocial impact of Klinefelter syndrome and attitudes towards diagnosis and screening
A. S. Herlihy1,2,3, R. I. McLachlan4,5,3, L. Gillam1,6,7, M. L. Cock3,2, J. L. Halliday1,7;
1Murdoch Childrens Research Institute, Parkville, Australia, 2Monash University, Clayton, Australia, 3Andrology Australia, Clayton, Australia, 4Prince Henry's Institute of Medical Research, Clayton, Australia, 5Monash University, Clayton, Austria, 6Royal Children's Hospital, Parkville, Australia, 7The University of Melbourne, Parkville, Australia.

EPL7.3 The clinical utility of web-based familial risk information for diabetes prevention: do people adopt risk-reducing behaviours?
M. Wijdenes-Pijl
1, D. Timmermans1, M. Cornel2, L. Henneman1,2;
1Department of Public and Occupational Health, EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, Netherlands, 2Department of Clinical Genetics, section Community Genetics, EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, Netherlands.

EPL7.4 Parents', patients' and professionals' views on genetic counselling for cleft lip and palate
R. M. MacLeod
, M. McAllister, A. Callard, J. Clayton-Smith;
The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom.

EPL7.5 New European recommendations for genetic counselling - the views of clinical genetics professionals
R. A. Pestoff
1,2, H. Kääriäinen3, L. Kerzin-Storrar4;
1Regional Oncogenetic Clinic, Oncology Department, Linköping University Hospital, Linköping, Sweden, 2Genetic Medicine, Manchester Academic Health Sciences Centre, CMFT and University of Manchester, Manchester, United Kingdom, 3National Insitute for Health and Welfare, Helsinki, Finland, 4Genetic Medicine, Manchester Academic Health Science Centre, CMFT and University of Manchester, Manchester, United Kingdom.

Closing remarks

Close of meeting